Studies in knockout mice and cultured chondrocytes indicate an important role of corin and atrial natriuretic peptide-mediated signaling in endochondral ossification and bone development. The ...
The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to setrusumab as a treatment to reduce fracture risk associated with osteogenesis imperfecta type I, III, or IV in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback